---
$id: https://graph.org.ai/products/commodity/51142572
$type: Product
source: UNSPSC
code: "51142572"
title: "Selegiline hydrochloride"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Selegiline hydrochloride

**UNSPSC Code**: 51142572
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor with the molecular formula C13H17N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6W731X367Q, chemically known as (-)-(r)-n,alpha-dimethyl-n-2-propynylphenethylamine monohydrochloride but more generally known as selegiline hydrochloride, which bears US NIH Compound Identifier 26758. European Medicines Agency schedules Selegiline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04347MIG. Most nations, for tariff and trade purposes, schedule selegiline hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, SELEGILINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Selegiline hydrochloride bears US NLM identifiers UMLS ID C0700467 and NCI Concept Code C47714. SMILES: C[C@H](CC1CCCCC1)N(C)CC#C.CL.

